NCT02491268View on ClinicalTrials.gov

A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

PHASE2CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

August 14, 2020

Study Completion Date

December 1, 2020

Conditions
Mild Cognitive Impairment
Interventions
DRUG

Cilostazol

DRUG

Placebo

Trial Locations (1)

564-8565

National Cerebral and Cardiovascular Center, Suita

All Listed Sponsors
lead

National Cerebral and Cardiovascular Center, Japan

OTHER

NCT02491268 - A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) | Biotech Hunter | Biotech Hunter